Halozyme Therapeutics
HALO
#2120
Rank
NZ$12.12 B
Marketcap
$95.75
Share price
-0.44%
Change (1 day)
43.44%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: NZ$12.12 Billion

As of September 2024 Halozyme Therapeutics has a market cap of NZ$12.12 Billion. This makes Halozyme Therapeutics the world's 2120th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$12.12 B57.12%
2023NZ$7.72 B-36.29%
2022NZ$12.11 B46.6%
2021NZ$8.26 B2.97%
2020NZ$8.02 B123.41%
2019NZ$3.59 B13.89%
2018NZ$3.15 B-22.31%
2017NZ$4.06 B119.88%
2016NZ$1.84 B-43.15%
2015NZ$3.24 B110.06%
2014NZ$1.54 B-26.02%
2013NZ$2.09 B126.61%
2012NZ$0.92 B-26.99%
2011NZ$1.26 B21.88%
2010NZ$1.03 B38.89%
2009NZ$0.74 B-5.59%
2008NZ$0.79 B10.29%
2007NZ$0.71 B-8.73%
2006NZ$0.78 B389.59%
2005NZ$0.16 B5.75%
2004NZ$0.15 B

End of Day market cap according to different sources

On Sep 20th, 2024 the market cap of Halozyme Therapeutics was reported to be:

NZ$12.12 Billion
by Yahoo Finance info icon info icon
NZ$12.12 Billion
by CompaniesMarketCap info icon info icon
NZ$12.12 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$2.93 B-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.341 T 10,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.74 B 161.67%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$269.47 B 2,121.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$233.51 B 1,825.15%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$638.74 B 5,165.87%๐Ÿ‡บ๐Ÿ‡ธ USA